29 results
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
, with the Health Care Laws; (ii) has not received any written notice or correspondence from any Governmental Entity alleging or asserting any noncompliance … with any Company Permit or Health Care Law; and (iii) has not received written notice that any Governmental Entity has taken or is intending to take
8-K
EX-1.1
STSA
Satsuma Pharmaceuticals Inc
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
, are, and at all times since June 21, 2016 have been, in compliance in all material respects with all Health Care Laws (defined herein), including, but not limited … or federal healthcare program. For purposes of this Agreement, “Health Care Laws” shall mean the federal Anti-kickback Statute (42 U.S.C. § 1320a-7b
8-K
EX-99.1
rg0lv5fpuwxgyl87qech
20 Sep 22
Satsuma Pharmaceuticals Announces Positive Results from the Ongoing STS101 ASCEND Phase 3 Open-label, Long-term Safety Trial
5:03pm
S-3
EX-1.2
3dw s17m1
23 Oct 20
Shelf registration
4:48pm
DEF 14A
ky0z 9pmjw4w50ibfla
24 Apr 20
Definitive proxy
4:14pm
10-K
rtm3 i9fh
10 Mar 20
Annual report
4:20pm